Search This Blog

Sunday, May 10, 2015

ViiV Healthcare begins phase III programme with dolutegravir/rilpivirine combination for HIV maintenance therapy | GSK

First programme to evaluate dual HIV maintenance therapy with dolutegravir and rilpivirine



ViiV Healthcare begins phase III programme with dolutegravir/rilpivirine combination for HIV maintenance therapy | GSK

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.